MedPath

Hepatitis Resource Network

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

HRN 004- Peginterferon a-2a Plus Ribavirin for Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon Therapy

Phase 3
Conditions
HIV Infections
Chronic Hepatitis C Infection in HIV Infected Persons
First Posted Date
2005-09-22
Last Posted Date
2005-10-25
Lead Sponsor
Hepatitis Resource Network
Registration Number
NCT00215839
Locations
🇺🇸

Mt. Sinai School of Medicine, New York, New York, United States

PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon

Phase 3
Completed
Conditions
Chronic Hepatitis C Infection in HIV-Infected Persons
HIV Infections
First Posted Date
2005-09-22
Last Posted Date
2005-10-25
Lead Sponsor
Hepatitis Resource Network
Target Recruit Count
300
Registration Number
NCT00215891
Locations
🇺🇸

Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy

Phase 3
Completed
Conditions
Chronic Hepatitis C Virus Infection
First Posted Date
2005-09-22
Last Posted Date
2005-09-22
Lead Sponsor
Hepatitis Resource Network
Target Recruit Count
600
Registration Number
NCT00215865
Locations
🇺🇸

Johns Hopkins Univesity School of Medicine, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath